The Marked Chart Wire · Business
AbCellera
AbCellera Q3 earnings beat analyst estimates
AbCellera Biologics reported third-quarter revenue of $10.639 million, exceeding the $8.416 million estimate. The company also posted an adjusted loss per share of $0.13, better than the expected $0.16.
